A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies
|
|||||
A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case 
Inventors of a system of sensors packaged in a thin film received a patent for their work that enables robotic devices to better sense conditions in the nearby environment. . . . → Read More: Ultra-Sensitive Nanotech Robot Skin Receives Patent  One comment - (Comments are closed)  Intellectual property  chemistry, engineering, materials science, nanotechnology, patent, physics, robotics, university, USPTO 
University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent Comments are closed Intellectual property biomedical, biotechnology, Europe, genomics, life sciences, patent, university, USPTO A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments. . . . → Read More: Patent Awarded for Nanoparticle Drug, Cannabis Delivery One comment - (Comments are closed) Intellectual property biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, USPTO U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells Comments are closed Intellectual property biomedical, biotechnology, cancer, clinical trials, Europe, genomics, life sciences, patent, pharmaceuticals, USPTO In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total. . . . → Read More: Biotech, Pharma Dominate U.S. Academic Patents Comments are closed Intellectual property biotechnology, medical device, NSF, patent, pharmaceuticals, university, USPTO A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration. . . . → Read More: FDA Fast-Tracks Heart Failure Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, FDA, heart disease, patent, pharmaceuticals, USPTO A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016. . . . → Read More: Survey: More Research Patents, Start-Ups in 2016 Comments are closed Business conditions, Intellectual property economics, entrepreneurs, licensing, patent, statistics, university, USPTO A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria. . . . → Read More: Patent Awarded for Live Bacterial Acne Treatment Comments are closed Intellectual property biomedical, clinical trials, life sciences, patent, pharmaceuticals, software, USPTO |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
